Assessment of lest ventricular hypertrophy and left ventricular diastolic dysfunction cardiovascular in patients of chronic renal failure by echocardiography
DOI:
https://doi.org/10.55489/njmr.12042022934Keywords:
Left ventricular hypertrophy, Left ventricular diastolic dysfunction, Chronic renal failure, EchocardiographyAbstract
Introduction - Chronic renal failure, regardless of the cause, is the presence of kidney damage or a reduced level of kidney function for three months or longer. It is a group of signs and symptoms brought on by slow and long-term renal damage. The most frequent cardiovascular finding in people on dialysis is LVH. Objective - To estimate the prevalence of left ventricular hypertrophy and left ventricular diastolic dysfunction by echocardiography in patients with chronic renal failure. Method – this was an observational cross-sectional study at the Department of General Medicine among IPD patients, Tertiary Care Hospital, Surat. Result - Left ventricular hypertrophy out of 34 cases 22 (64.71%) cases were show left ventricular hypertrophy with an odd ratio of 3.208 (1.049, 9.81) and a p-value 0.0378 which was statically significant. prevalence of diastolic dysfunction was 79%. comparison of renal function test and echocardiographic change of chronic renal failure. In the renal function test serum, creatinine and EGFR were show a p-value < 0.001 which was statistically significant. Conclusion - Cardiac dysfunction and LVH are frequently noted in individuals with chronic renal failure at the time of commencement of dialysis. cardiovascular abnormalities in the form of LVH and diastolic dysfunction which antedate severe systolic dysfunction are frequently observed in milder degrees of chronic renal failure
References
1. P. Dangri, S. Agrawal, OP. Kalra, S. Rajpal Echocardiographic assesment of left ventricular hypertrophy in patients of chron-ic renal failure, Indian Journal of Nephrology, 2003;13:92- 97. Doi: https://doi.org/10.4103/0971-4065.34877
2. Rachel J. Middlrton, Patrick S. Pafrey and Robert N. Foley, Left Ventricuar Hypertrophy in renal patient, J. Am. SocNeph-rol 2001;13:1079-1084. Doi: https://doi.org/10.1681/ASN.V1251079 PMid:11316868
3. Christopher G Winerals. Clinical evaluation and manifesta-tions of chronic renal failure.In: Richard J Johnson, John Feehally editors, comprehensive clinical Nephrology. 2nd edi-tion.2004:857-872.
4. Robert N Foley, Patrick S Parfrey, Gloria M kent, John DHar-nett, David C Murray and Paul E Barre, Serial changes in echocardiographic parameters and cardiac failure in end stage renal disease, J. Am. Soc. Nephro 2000;11:912-916. Doi: https://doi.org/10.1681/ASN.V115912 PMid:10770969
5. BraunwaldEugene, Braunwald'sHeart Disease: A Textbook of Cardiovascular Medicine. 11th edition.2018:447
6. Brawnwald Eugene, Braunwald's Heart Disease: A Textbook-ofCrdiovascular Medicine. 11thedition. 2018:1294
7. Fellner SK, Lang R M, Neumann A, Korcarz C and Borow K M. Cardiovascular consequences of correction of anemia of renal failure with 38.erythropoietin. Kidney Int 1993;44:1309-1315. Doi: https://doi.org/10.1038/ki.1993.383 PMid:8301932
8. Elhendy A, O'Leary E.L, Xie F, McGrain A.C, Anderson J.R, Porter T.R, Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol. 2004; 44: 2185-2191. Doi: https://doi.org/10.1016/j.jacc.2004.08.059 PMid:15582317
9. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S and Traverso G B.Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long term antihypertensive therapy. Kidney Int 1993:44:881-886. Doi: https://doi.org/10.1038/ki.1993.326 PMid:8258965
10. Amoako YA, Laryea DO, Bedu-Addo G, Nkum BC, Plange-Rhule J. Left ventricular hypertrophy among Chronic Renal Failure patients in Ghana.PanAfr Med J. 2017;28:79. Published 2017 Sep 27. Doi: https://doi.org/10.11604/pamj.2017.28.79.9183 PMid:29255549 PMCid:PMC5724957
11. Vankayala R, et al., Gold nanoshells-mediated bimodal pho-todynamic and photothermal cancer treatment using ultra-low doses of near infrared light, Biomaterials (2014), Doi: https://doi.org/10.1016/j.biomaterials.2014.03.065 PMid:24731706
12. Rao T, Karwa M, Wanjari A Left ventricular dysfunction among chronic kidney disease patients: a cross sectional study. Int J Adv Med 2018;5:1093-9. Doi: https://doi.org/10.18203/2349-3933.ijam20183390
13. Chillo P, Lwakatare J, Janabi M, Matuja W, Greve G. Low prevalence of cardiovascular disease risk factors among pri-mary school children in Tanzania: An opportunity for pri-mordial prevention? Tanzania Medical J 2009;24:9-14. Doi: https://doi.org/10.4314/tmj.v24i2.53280
14. Agarwal SK, Norby FL, Whitsel EA, Soliman EZ, Chen LY, Loehr LR, Fuster V, Heiss G, Coresh J, Alonso A. Cardiac Au-tonomic Dysfunction and Incidence of Atrial Fibrillation: Re-sults From 20 Years Follow-Up. J Am Coll Cardiol. 2017 Jan 24;69(3):291-299. Doi: https://doi.org/10.1016/j.jacc.2016.10.059 PMid:28104071 PMCid:PMC5260487
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mahipal Chaudhary, Kaushik Hadiya, Prafful Kothari, Ashok Choudhary

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author/s retain the copyright of their article, with first publication rights granted to Medsci Publications.
